SK282729B6 - Deriváty indol-2,3-dión-3-oxímu, spôsob ich prípravy, použitie a farmaceutická kompozícia s ich obsahom - Google Patents

Deriváty indol-2,3-dión-3-oxímu, spôsob ich prípravy, použitie a farmaceutická kompozícia s ich obsahom Download PDF

Info

Publication number
SK282729B6
SK282729B6 SK676-98A SK67698A SK282729B6 SK 282729 B6 SK282729 B6 SK 282729B6 SK 67698 A SK67698 A SK 67698A SK 282729 B6 SK282729 B6 SK 282729B6
Authority
SK
Slovakia
Prior art keywords
phenyl
dione
methyl
alkyl
oxime
Prior art date
Application number
SK676-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK67698A3 (en
Inventor
Frank W�Tjen
Jorgen Drejer
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of SK67698A3 publication Critical patent/SK67698A3/sk
Publication of SK282729B6 publication Critical patent/SK282729B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK676-98A 1996-10-01 1997-10-01 Deriváty indol-2,3-dión-3-oxímu, spôsob ich prípravy, použitie a farmaceutická kompozícia s ich obsahom SK282729B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK106996 1996-10-01
DK127796 1996-11-13
PCT/DK1997/000418 WO1998014447A1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives

Publications (2)

Publication Number Publication Date
SK67698A3 SK67698A3 (en) 1998-11-04
SK282729B6 true SK282729B6 (sk) 2002-11-06

Family

ID=26065167

Family Applications (1)

Application Number Title Priority Date Filing Date
SK676-98A SK282729B6 (sk) 1996-10-01 1997-10-01 Deriváty indol-2,3-dión-3-oxímu, spôsob ich prípravy, použitie a farmaceutická kompozícia s ich obsahom

Country Status (29)

Country Link
US (3) USRE38200E1 (ja)
EP (1) EP0869958B1 (ja)
JP (1) JP3319762B2 (ja)
KR (1) KR100492052B1 (ja)
CN (1) CN1093859C (ja)
AT (1) ATE286052T1 (ja)
AU (1) AU716435B2 (ja)
BG (1) BG63874B1 (ja)
BR (1) BR9706765A (ja)
CA (1) CA2238410C (ja)
CZ (1) CZ297938B6 (ja)
DE (1) DE69732090T2 (ja)
DK (1) DK0869958T3 (ja)
EE (1) EE9800144A (ja)
ES (1) ES2235253T3 (ja)
HK (1) HK1017682A1 (ja)
HU (1) HU225145B1 (ja)
IL (1) IL124563A (ja)
IS (1) IS2123B (ja)
NO (1) NO310722B1 (ja)
NZ (1) NZ330456A (ja)
PL (1) PL193041B1 (ja)
PT (1) PT869958E (ja)
RU (1) RU2190612C2 (ja)
SI (1) SI0869958T1 (ja)
SK (1) SK282729B6 (ja)
TR (1) TR199800956T1 (ja)
UA (1) UA54403C2 (ja)
WO (1) WO1998014447A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
DE69922936T2 (de) * 1998-03-31 2005-12-08 Neurosearch A/S Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten
WO2000071102A2 (en) * 1999-05-19 2000-11-30 Neurosearch A/S Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
ES2266214T3 (es) 2000-01-24 2007-03-01 Neurosearch A/S Derivados de isatina con actividad neurotrofica.
IT1318636B1 (it) * 2000-07-21 2003-08-27 Roberto Pellicciari Derivati dell'acido 2- o 3- tenoico ad attivita' antagonista deirecettori del glutammato.
WO2002064139A1 (en) * 2001-02-15 2002-08-22 Neurosearch A/S Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
MXPA04000358A (es) 2001-07-13 2004-05-04 Pharmacia & Up John Company Hexahidroazepino (4,5-g) indoles e indolinas como ligandos del receptor 5-ht.
WO2004018466A2 (en) * 2002-08-22 2004-03-04 Neurosearch A/S A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
CA2630617C (en) 2005-11-23 2014-03-25 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2007115403A1 (en) * 2006-04-10 2007-10-18 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20080004282A1 (en) * 2006-04-10 2008-01-03 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2008031831A2 (en) * 2006-09-12 2008-03-20 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
US20080108622A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
US20080108603A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
WO2010104324A2 (ko) * 2009-03-10 2010-09-16 한국과학기술연구원 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를 가지는 할로겐화 이소인돌론 화합물, 및 이의 제조 방법 및 용도
CN102653538A (zh) * 2011-03-04 2012-09-05 爱斯医药科技(南京)有限公司 Spd-502的制备方法
ES2767707T3 (es) * 2015-04-29 2020-06-18 Janssen Pharmaceutica Nv Compuestos de indolona y su uso como moduladores de receptor AMPA
SG11201708190UA (en) 2015-04-29 2017-11-29 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
EP3288936B1 (en) 2015-04-29 2020-05-06 Janssen Pharmaceutica NV Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
BR112017023038A2 (pt) 2015-04-29 2018-07-03 Janssen Pharmaceutica Nv imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9204914A (es) * 1991-08-28 1993-07-01 Frank Watjen Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende.
US5721230A (en) 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
DE69407407T2 (de) * 1993-05-13 1998-04-09 Neurosearch As Ampa antagonisten und behandlungsmethode
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
JP3164371B2 (ja) * 1994-09-14 2001-05-08 ノイロサーチ アクティーゼルスカブ インドール−2,3−ジオン−3−オキシム誘導体、その製造および使用
WO1996008495A1 (en) * 1994-09-14 1996-03-21 Neurosearch A/S Fused indole and quinoxaline derivatives, their preparation and use
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму

Also Published As

Publication number Publication date
DE69732090D1 (de) 2005-02-03
ES2235253T3 (es) 2005-07-01
SK67698A3 (en) 1998-11-04
TR199800956T1 (xx) 1998-12-21
WO1998014447A1 (en) 1998-04-09
PL193041B1 (pl) 2007-01-31
CN1093859C (zh) 2002-11-06
NO982466D0 (no) 1998-05-29
EP0869958A1 (en) 1998-10-14
RU2190612C2 (ru) 2002-10-10
NZ330456A (en) 1998-11-25
DK0869958T3 (da) 2005-04-18
EP0869958B1 (en) 2004-12-29
UA54403C2 (uk) 2003-03-17
US6693111B1 (en) 2004-02-17
IL124563A (en) 2005-05-17
JP3319762B2 (ja) 2002-09-03
CA2238410C (en) 2007-06-12
HU225145B1 (en) 2006-07-28
IS2123B (is) 2006-07-14
CN1207100A (zh) 1999-02-03
BG63874B1 (bg) 2003-04-30
CA2238410A1 (en) 1998-04-09
IS4748A (is) 1998-05-18
NO982466L (no) 1998-07-31
USRE38200E1 (en) 2003-07-22
BR9706765A (pt) 1999-09-14
AU4376897A (en) 1998-04-24
ATE286052T1 (de) 2005-01-15
SI0869958T1 (en) 2005-06-30
KR100492052B1 (ko) 2005-09-30
MX9804365A (es) 1998-10-31
EE9800144A (et) 1998-10-15
CZ160698A3 (cs) 1998-10-14
PT869958E (pt) 2005-05-31
HUP9901630A2 (hu) 1999-08-30
CZ297938B6 (cs) 2007-05-02
KR19990071823A (ko) 1999-09-27
NO310722B1 (no) 2001-08-20
US6124285A (en) 2000-09-26
IL124563A0 (en) 1998-12-06
PL327073A1 (en) 1998-11-23
HUP9901630A3 (en) 2001-11-28
JP2000501432A (ja) 2000-02-08
AU716435B2 (en) 2000-02-24
BG102489A (en) 1999-04-30
DE69732090T2 (de) 2005-12-29
HK1017682A1 (en) 1999-11-26

Similar Documents

Publication Publication Date Title
SK282729B6 (sk) Deriváty indol-2,3-dión-3-oxímu, spôsob ich prípravy, použitie a farmaceutická kompozícia s ich obsahom
JP3439215B2 (ja) Ampa拮抗薬およびそれを用いての治療方法
US20060229311A1 (en) Isatine derivatives with neurotrophic activity
HU211632A9 (en) Novel isatinoxime derivatives, their preparation and use
EP1066037B1 (en) Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
EP0781284B1 (en) Indole-2,3-dione-3-oxime derivatives, their preparation and use
US5599812A (en) Tricyclic pyrrolopyrazine 5-HT3 -active compounds
US6936604B2 (en) Bridged bicyclic amino acid-derived [1,4]benzodiazepine vasopressin receptor antagonists
MXPA98004365A (en) Novel indole-2,3-dione-3-oxime derivatives

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20111001